
CAS Name: Tricarbonic acid bis(1,1-dimethylethyl)ester
Percent Composition: C 50.38%, H 6.92%, O 42.70%
Literature References: Mild reagent which converts most primary amines quantitatively into their corresponding isocyanate. Prepn: C. S. Dean, D. S. Tarbell, Chem. Commun. 1969, 728; B. M. Pope et al., Org. Synth. 57, 45 (1977). Kinetic study: eidem, J. Org. Chem. 43, 2410 (1978). Use in prepn of isocyanates: H. W. I. Peerlings, E. W. Meijer, Tetrahedron Lett. 40, 1021 (1999); of polyurethanes: R. V. Versteegen et al., Angew. Chem. Int. Ed. 38, 2917 (1999).
CAS Name: Bis(pyridine)iodine(1+) tetrafluoroborate(1-)
Additional Names: Barluenga's reagent; IPy2BF4
Percent Composition: C 32.29%, H 2.71%, I 34.12%, N 7.53%, B 2.91%, F 20.43%
Literature References: Mild source of iodonium ions in organic synthesis. Prepn: J. Barluenga et al., Angew. Chem. Int. Ed. 24, 319 (1985). Oxidation of alcohols: idem et al., Chem. Eur. J. 10, 4206 (2004). Brief review: K. Muñiz, Synlett 1999, 1679. Review of iodination chemistry: J. Barluenga, Pure Appl. Chem. 71, 431-436 (1999).
CAS Name: 6',7-Epoxy-6-methoxy-2-methyl-oxyacanthan-12'-ol
Percent Composition: C 74.43%, H 5.88%, N 5.11%, O 14.58%
Literature References: Minor alkaloid from bark of Daphnandra micrantha (Tul.) Benth., Monimiaceae. Isoln: Pyman, J. Chem. Soc. 105, 1679 (1914). Structure: Bick, Todd, ibid. 1950, 1606. Revised structure and stereochemistry: Bick et al., Tetrahedron Lett. 1972, 33. Biogenesis: I. Ralph, C. Bick, Heterocycles 16, 2105 (1981).
CAS Name: 8-Hydroxy-5-oxoophiobola-3,6,19-trien-25-oic acid
Additional Names: ophiobolin D
Percent Composition: C 74.96%, H 9.06%, O 15.98%
Literature References: Minor antibiotic metabolite produced by Cephalosporium caerulens. Exhibits weak activity against Staphylococcus aureus. Isolation, structure elucidation and physical data: Itai et al., Tetrahedron Lett. 1967, 4111; Nozoe et al., ibid. 4113. Crystal structure: Itai et al., Acta Crystallogr. 25B, 872 (1969). Synthetic studies on related compounds: P. C. Dutta, T. K. Das, Synth. Commun. 6, 253 (1976); W. G. Dauben, D. S. Hart, J. Org. Chem. 42, 922 (1977); R. K. Boeckman et al., ibid. 3630.
CAS Name: (1S)-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinol
Additional Names: 1,2,3,4-tetrahydro-6-methoxy-2-methyl-1-veratryl-7-isoquinolinol
Percen...
Literature References: Minor opium alkaloid. Constitutes about 0.003% of Turkish opium. Isoln: Hesse, Ann. 282, 213 (1894). Structure: Späth, Epstein, Ber. 59B, 2791 (1926). Synthesis: Schöpf, Thierfelder, Ann. 537, 143 (1939); Billek, Monatsh. Chem. 87, 106 (1956).
CAS Name: 3,4-Dihydroxybenzoic acid
Percent Composition: C 54.55%, H 3.92%, O 41.52%
Literature References: Minute amounts are found in wheat grains, in wheat seedlings, and in many other plants: L. Hörhammer, A. Scherm, Arch. Pharm. 288, 441 (1955). Prepd by the alkaline fusion of vanillin: Tiemann, Haarmann, Ber. 7, 617 (1874); Pearl, J. Am. Chem. Soc. 68, 2180 (1946); Org. Synth. coll. vol. III, 745 (1955).
Additional Names: Carbon bisulfide; dithiocarbonic anhydride
Percent Composition: C 15.77%, S 84.23%
Literature References: Minute amounts occur in coal tar and in crude petroleum. Prepd on an industrial scale by heating charcoal with vaporized sulfur; from sulfur and natural gas: Faith, Keyes Clark's Industrial Chemicals, F. A. Lowenheim, M. K. Moran, Eds. (Wiley-Interscience, New York, 4th ed., 1975) pp 224-229. Laboratory purification: Glemser in Handbook of Preparative Inorganic Chemistry vol. 1, G. Brauer, Ed. (Academic Press, New York, 2nd ed., 1963) p 652. Review of production and uses: Bushell, Chem. Ind. (London) 1961, 1465; R. W. Timmerman in Kirk-Othmer Encyclopedia of Chemical Technology vol. 4 (Wiley-Interscience, New York, 3rd ed., 1978) pp 742-757; of toxicology and human exposure: Toxicological Profile for Carbon Disulfide (PB97-121073, 1996) 252 pp.
CAS Name: 7-Fluoro-1-methyl-3-(methylsulfinyl)-4(1H)-quinolinone
Additional Names: flosequinonTrademarks: Manoplax (Boots)
Percent Composition: C 55.22%, H 4.21%, F 7.94%, N 5.85%, O 13.37%,...
Literature References: Mixed arterial and venous vasodilator. Prepn: R. V. Davies et al., DE 3011994; eidem, US 4302460 (1980, 1981 both to Boots). Pharmacology: J. G. Smith, G. T. Kinasewitz, J. Cardiovasc. Pharmacol. 8, 878 (1986); M. F. Sim et al., Br. J. Pharmacol. 94, 371 (1988). HPLC determn in plasma, serum and urine: M. B. Slegowski et al., J. Chromatogr. 425, 227 (1988). Pharmacokinetics and hemodynamics in humans: A. J. Cowley et al., J. Hypertens. 2, Suppl. 3, 547 (1984); R. D. Wynne et al., Eur. J. Clin. Pharmacol. 28, 659 (1985). Preliminary evaluation in hypertension: A. J. Cowley et al., ibid. 33, 203 (1987); in congestive heart failure: P. D. Kessler, M. Packer, Am. Heart J. 113, 137 (1987); P. D. Kessler et al., J. Cardiovasc. Pharmacol. 12, 6 (1988). Clinical study in chronic heart failure: A. J. Cowley et al., Br. Med. J. 297, 169 (1988).
CAS Name: 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol
Additional Names: 4-[2-hydroxy-3-(isopropylamino)propoxy]indole; prinodololTrademarks: Betapindol (Helvepharm); Blocklin L (Sh...
Literature References: Mixed b-adrenergic blocker and serotonin 5HT1A-receptor antagonist. Prepn: NL 6601040; F. Troxler, A. Hofmann, US 3471515 (1966, 1969 both to Sandoz). HPLC determn in plasma: H. Smith, J. Chromatogr. 415, 95 (1987). Symposia on cardiovascular pharmacology and clinical studies: Am. Heart J. 104, Suppl. 2, pt. 2, 333-520 (1982); Br. J. Clin. Pharmacol. 13, Suppl. 2, 143S-450S (1982). Effect on serotonin levels in rat brain: L. J. Dreshfield et al., Neurochem. Res. 21, 557 (1996). Clinical trial with fluoxetine, q.v., in depression: V. Pérez et al., Lancet 349, 1594 (1997).
CAS Name: 1-(Diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazinePercent Composition: C 78.70%, H 7.74%, N 6.33%, O 7.23%
Literature References: Mixed calcium channel blocker and serotonin (5-HT2) receptor antagonist. Prepn: R. Foguet et al., EP 97340; eidem, US 4883797 (1984, 1989 both to Ferrer); S. Gubert et al., Arzneim.-Forsch. 37, 1103 (1987). Clinical pharmacokinetics and tolerability: M. Farré et al., Methods Find. Exp. Clin. Pharmacol. 19, 343 (1997). Cerebrovascular study in goats: G. Torregrosa et al., Arzneim.-Forsch. 49, 668 (1999); in rabbits: N. Kuridze et al., J. Neurol. Sci. 175, 13 (2000). Mechanism of blockade: A. Ruiz-Nuno et al., Eur. J. Pharmacol. 411, 289 (2001).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
